Treatment of neurocutaneous syndrome, including compositions, methods and uses thereof

Abstract

A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and/or at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.

What is claimed is: 
     
         1 . A treatment protocol for use in the treatment of neurocutaneous syndrome, comprising:
 administering to a patient suffering from neurocutaneous syndrome a detoxification formula comprising a homeopathic liquid remedy designed for drainage and detoxification from internal toxins affecting the internal organ systems.   
     
     
         2 . The treatment protocol of  claim 1  further comprising:
 administering to a patient in need thereof, at least one xanthone component. 
 
     
     
         3 . The treatment protocol of  claim 2 , further comprising administering to a patient in need thereof, at least one herbal component, at least one vitamin component, or a combination thereof. 
     
     
         4 . The treatment protocol of  claim 2 , wherein the detoxification component comprises Berberis Vulgaris 2X, 10X, 30X, 200X, Colocynthis 3X, 10X, 30X, 200X, Veratrum Album 3X, 10X, 30X, 200X, Aranea Diadema 6X, Calcarea Phosphorica 12X, Equisetum Hyemale 4X, Ferrum Iodatum 12X, Fumaria Officinalis 4X, Gentiana Lutea 5X, Geranium Robertianum 4X, Levothyroxine 12X, Myosotis Arvensis 3X, Nasturtium Aquaticum 4X, Natrum Sulphuricum 4X, Pinus Sylvestris 4X, Sarsaparilla 6X, Scrophularia Nodosa 3X, Teucrim Scorodonia 3X, Veronica Officinalis 3X, Bryonia Alba 3X, 6X, 10X, 15X, 30X, 200X, 1000X, Colocynthis 3X, 10X, 30X, 200X, Lycopodium Clavatum 3X, 10X, 30X, 200X, 1000X, Nux Vomica 3X, 10X, 15X, 30X, 200X, 1000X, Ethyl Alcohol, and Purified Water USP. 
     
     
         5 . The treatment protocol of  claim 4 , wherein the at least one mangosteen component comprises an extract of a mangosteen fruit. 
     
     
         6 . The treatment protocol of  claim 4 , wherein the at least one mangosteen component comprises mangosteen juice. 
     
     
         7 . The treatment protocol of  claim 4 , further comprising administering to the patient in need thereof, at least one herbal component comprising Garlic, Olive Leaf Extract, Citrus Seed Extract, Goldenseal, Aloe Vera, Pomegranate, Oregano Leaf, Clove Bud, Black Walnut Hull, Peppermint Leaf, Black Cumin Seed, Winter Melon Seed, Gentian Root, Wormwood Bark, Hyssop Leaf, Cramp Bark, Thyme Leaf, Fennel Seed, Pumpkin Seed, Caprylic Acid, Rosemary, Papaya, Rangoon Creeper, Psyllium Seed Husk, Atlantic Kelp, Corn Silk, Fo-Ti, Chinese Rhubarb Root, Peppermint Leaf, Black Cumin Seed, Cinnamon Bark, Fennel Seed, Ginger Root, Orange Peel Extract, Clove Bulb, Cascara Sagrada, Slippery Elm Bark, Molasses, Carob, Chinese Rhubarb Root, Sage, Thyme Leaf, Ginger Root, Clove Bulb, Cayenne Fruit, Rosemary Leaf, Alfalfa Oil, Licorice Root, Chamomile, Grapefruit Seed Extract, Echinacea, Atlantic Kelp, Chicory, Corn Silk, Fennel Seed, Peppermint Leaf, Safflower Oil Powder, or a combination thereof. 
     
     
         8 . The treatment protocol of  claim 4 , further comprising administering to the patient in need thereof, at least one vitamin component comprising vitamin B, folic acid, minerals, zinc, calcium, magnesium oxide or citrate, vitamin E, vitamin C, Omega oils, acidofilus, bifidus, lactobacillus, amino acids, digestive enzymes, selenium, L-glutathione or a combination thereof. 
     
     
         9 . A method of treating a patient having neurocutaneous syndrome caused by dental toxins, comprising:
 providing at least one targeted questionnaire to the patient;   providing a blood dental biocompatibility test;   providing at least one xanthone component;   providing a detoxification component, wherein the detoxification component comprises a combination of Berberis Vulgaris, Colocynthis, Veratrum Album, Aranea Diadema, Calcarea Phosphorica, Equisetum Hyemale, Ferrum Iodatum, Fumaria Officinalis, Gentiana Lutea, Geranium Robertianum, Levothyroxine, Myosotis Arvensis, Nasturtium Aquaticum, Natrum Sulphuricum, Pinus Sylvestris, Sarsaparilla, Scrophularia Nodosa, Teucrim Scorodonia, Veronica Officinalis, Bryonia Alba, Colocynthis, Lycopodium Clavatum, Nux Vomica, Ethyl Alcohol, Purified Water USP;   administering the at least one targeted questionnaire to the patient to provide targeted questionnaire results;   administering a blood dental biocompatibility test to the patient to provide biocompatibility test results, wherein the targeted questionnaire results and the biocompatibility test results are combined to provide a set of results;   administering the at least one xanthone component to the patient in a dosing regimen that is based on the combined set of results from the combination of the targeted questionnaire results and the biocompatibility test results; and   administering the detoxification component to the patient in a dosing regimen that is based on the combined set of results from the combination of the targeted questionnaire results and the biocompatibility test results.   
     
     
         10 . The method of  claim 9 , further comprising:
 providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.   
     
     
         11 . The method of  claim 9 , wherein the at least one xanthone component comprises at least one mangosteen component. 
     
     
         12 . The method of  claim 11 , wherein the at least one mangosteen component comprises an extract of a mangosteen fruit. 
     
     
         13 . The method of  claim 11 , wherein the at least one mangosteen component comprises a suitable amount of the extract of the mangosteen fruit. 
     
     
         14 . The method of  claim 11 , wherein the at least one mangosteen component comprises mangosteen juice. 
     
     
         15 . A method of treating a patient having neurocutaneous syndrome caused by dental toxins, comprising:
 providing at least one targeted questionnaire to the patient;   providing a blood dental biocompatibility test;   providing at least one mangosteen component;   providing a detoxification component, wherein the detoxification component comprises the combination of ubichinon, coenzyme, BERBERIS-HOMACCORD, that comprises berberis vulgaris, colocynthis, veratrum album, ethanol, and purified water; LYPHOSOT, that comprises juglans regia, myosotis arvensis, scrophularia nodosa, teucrium scorodonia, veronica officinalis, geranium robertianum, urtica urens, equisetum hyemale, fumaria officinalis, natrium sulfuricum, pinus sylvestris, gentiana lutea, apis mellifica, fucus vesiculosus, sarsaparilla, calcium phosphoricum, ethanol, and purified water; and NUX VOMICA-HOMACCORD, that consists of bryonia, nux vomica, colocynthis, lycopodium clavatum, ethanol, and purified water;   administering the at least one targeted questionnaire to the patient to provide targeted questionnaire results;   administering a blood dental biocompatibility test to the patient to provide biocompatibility test results, wherein the targeted questionnaire results and the biocompatibility test results are combined to provide a set of results;   administering the at least one mangosteen component to the patient in a dosing regimen that is based on the combined set of results from the combination of the targeted questionnaire results and the biocompatibility test results; and   administering the at least one detoxification component to the patient in a dosing regimen that is based on the combined set of results from the combination of the targeted questionnaire results and the biocompatibility test results.   
     
     
         16 . The method of  claim 15 , wherein the at least one mangosteen component comprises an extract of a mangosteen fruit. 
     
     
         17 . The method of  claim 15 , wherein the at least one mangosteen component comprises a suitable amount of the extract of the mangosteen fruit. 
     
     
         18 . The method of  claim 15 , wherein the at least one mangosteen component comprises mangosteen juice. 
     
     
         19 . The method of  claim 15 , further comprising providing and administering massage therapy to the patient. 
     
     
         20 . The method of  claim 19 , wherein massage therapy comprises lymph drainage massage therapy.